US FDA cleared INDs for [225 Ac]Ac-AKY-1189 and [64 Cu]Cu-AKY-1189 for initiation of broad NECTINIUM-2 Phase 1b trial NECTINIUM-2 will evaluate [225 Ac]Ac-AKY-1189 for the treatment of patients with ...
H3, to be featured in two poster presentationsData facilitate initial understanding of AKY-2519 biodistribution and predicted ...
Add Yahoo as a preferred source to see more of our stories on Google. ASHLAND After five years in the driver’s seat of Visit AKY — Ashland’s tourism and convention bureau — Brandy Clark has decided to ...
Add Yahoo as a preferred source to see more of our stories on Google. ASHLAND Visit AKY’s new executive director is predicting a fun, eventful August. Celest Kouns, who has been leading tourism in ...
A breakthrough in cancer treatment may soon change how some of the most aggressive tumors are managed. A small, specially-designed protein known as AKY-1189 has shown it can carry radiation directly ...
SHENZHEN, China, April 10, 2026 /PRNewswire/ -- AKEEYO, a leading developer of intelligent recording solutions for two- and four-wheeled vehicles, will exhibit at Global Sources Hong Kong 2026 (April ...
FDA fast track enables increased FDA-company interactions and potential rolling BLA submission to accelerate development for serious diseases with unmet need. AKY-1189 uses a miniprotein ...
(RTTNews) - Aktis Oncology, Inc. (AKTS), Tuesday announced that the U.S. Food and Drug Administration has granted Fast Track designation to AKY-1189 for the treatment of adult patients with locally ...
Progressing vision to expand the reach of targeted radiopharmaceuticals to large patient populations Anticipating multiple milestones in the next 12 months, including initiation of Phase 1b clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results